Indications and outcome of splenectomy in hematologic disease

Journal of Visceral Surgery

Volumn 154, Issue 6, 2017, Pages 421-429

  Bonnet, S ^a   Guedon A ^a   Ribeil, J A ^b,c   Suarez, F ^b,c   Tamburini, J ^a,b   Gaujoux, S ^a,b  

^a AP–HP ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Hematology; Hemolysis; Hypersplenism; Lymphoproliferative syndrome; Myeloproliferative syndrome; Splenectomy; Splenomegaly

Indexed keywords

COMPLICATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LAPAROSCOPY; MALE; PATHOLOGY; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SPLENECTOMY; SPLENOMEGALY; TREATMENT OUTCOME;

FEMALE; HEMATOLOGIC DISEASES; HUMANS; LAPAROSCOPY; MALE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SPLENECTOMY; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 85036554907     PISSN: 18787886     EISSN: 18787878     Source Type: Journal    
DOI: 10.1016/j.jviscsurg.2017.06.011     Document Type: Short Survey

References (56)

1. Bagrodia, N., Button, A.M., Spanheimer, P.M., et al. Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 149:10 (2014), 1022–1029.
2. Baird, R.N., Macpherson, A.I., Richmond, J., Red-blood-cell survival after splenectomy in congenital spherocytosis. Lancet Lond Engl 2:7733 (1971), 1060–1061.
3. Casale, M., Perrotta, S., Splenectomy for hereditary spherocytosis: complete, partial or not at all?. Expert Rev Hematol 4:6 (2011), 627–635.
4. Schilling, R.F., Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis–a personal view. Br J Haematol 145:6 (2009), 728–732.
5. Buesing, K.L., Tracy, E.T., Kiernan, C., et al. Partial splenectomy for hereditary spherocytosis: a multi-institutional review. J Pediatr Surg 46:1 (2011), 178–183.
6. Pincez, T., Guitton, C., Gauthier, F., et al. Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study. Blood 127:12 (2016 Mar 24), 1616–1618.
7. Sandler, A., Winkel, G., Kimura, K., et al. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J Pediatr Surg 34:7 (1999), 1077–1078.
8. Agre, P., Asimos, A., Casella, J.F., et al. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 315:25 (1986), 1579–1583.
9. Durakbasa, C.U., Timur, C., Sehiralti, V., et al. Pediatric splenectomy for hematological diseases: outcome analysis. Pediatr Surg Int 22:8 (2006), 635–639.
10. Al-Salem, A.H., Indications and complications of splenectomy for children with sickle cell disease. J Pediatr Surg 41:11 (2006), 1909–1915.
11. al-Salem, A.H., Qaisaruddin, S., Nasserallah, Z., et al. Splenectomy in patients with sickle-cell disease. Am J Surg 172:3 (1996), 254–258.
12. Brousse, V., Elie, C., Benkerrou, M., et al. Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol 156:5 (2012), 643–648.
13. Akpek, G., McAneny, D., Weintraub, L., Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. Am J Hematol 61:2 (1999), 98–102.
14. Gertz, M.A., Management of cold haemolytic syndrome. Br J Haematol 138:4 (2007), 422–429.
15. Swiecicki, P.L., Hegerova, L.T., Gertz, M.A., Cold agglutinin disease. Blood 122:7 (2013), 1114–1121.
16. Neunert, C., Lim, W., Crowther, M., et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:16 (2011), 4190–4207.
17. George, J.N., el-Harake, M.A., Raskob, G.E., Chronic idiopathic thrombocytopenic purpura. N Engl J Med 331:18 (1994), 1207–1211.
18. Provan, D., Stasi, R., Newland, A.C., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115:2 (2010), 168–186.
19. Ghanima, W., Godeau, B., Cines, D.B., et al. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 120:5 (2012), 960–969.
20. Kojouri, K., Vesely, S.K., Terrell, D.R., et al. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104:9 (2004), 2623–2634.
21. Mikhael, J., Northridge, K., Lindquist, K., et al. Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: a systematic review. Am J Hematol 84:11 (2009), 743–748.
22. Sailer, T., Lechner, K., Panzer, S., et al. The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy. Haematologica 91:8 (2006), 1041–1045.
23. Cooper, N., State of the art - how I manage immune thrombocytopenia. Br J Haematol 177:1 (2017), 39–54.
24. Bell, W.R., Braine, H.G., Ness, P.M., et al. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:6 (1991), 398–403.
25. Aqui, N.A., Stein, S.H., Konkle, B.A., et al. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apheresis 18:2 (2003), 51–54.
26. Kappers-Klunne, M.C., Wijermans, P., Fijnheer, R., et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 130:5 (2005), 768–776.
27. Beloncle, F., Buffet, M., Coindre, J.-P., et al. Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Transfusion 52:11 (2012), 2436–2444.
28. Iannitto, E., Tripodo, C., How I diagnose and treat splenic lymphomas. Blood 117:9 (2011), 2585–2595.
29. Dungarwalla, M., Appiah-Cubi, S., Kulkarni, S., et al. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis. Br J Haematol 143:1 (2008), 71–74.
30. Ben-Yehuda, D., Polliack, A., Okon, E., et al. Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable. J Clin Oncol 14:9 (1996), 2431–2434.
31. Olszewski, A.J., Ali, S., Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma. Ann Hematol 93:3 (2014), 449–458.
32. Habermann, T.M., Rai, K., Historical treatments of in hairy cell leukemia, splenectomy and interferon: past and current uses. Leuk Lymphoma 2 (2011), 18–20.
33. Mesa, R.A., Tefferi, A., Palliative splenectomy in myelofibrosis with myeloid metaplasia. Leuk Lymphoma 42:5 (2001), 901–911.
34. Kvasnicka, H.M., Thiele, J., Werden, C., et al. Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 80:4 (1997), 708–719.
35. Mesa, R.A., How I treat symptomatic splenomegaly in patients with myelofibrosis. Blood 113:22 (2009), 5394–5400.
36. Mesa, R.A., Elliott, M.A., Tefferi, A., Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Blood Rev 14:3 (2000), 121–129.
37. Harrison, C., Kiladjian, J.-J., Al-Ali, H.K., et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med 366:9 (2012), 787–798.
38. Buzelé R., Barbier, L., Sauvanet, A., et al. Medical complications following splenectomy. J Visc Surg 153:4 (2016), 277–286.
39. Wu, Z., Zhou, J., Pankaj, P., et al. Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy. Surg Endosc 26:10 (2012), 2758–2766.
40. Poulin, E.C., Mamazza, J., Schlachta, C.M., Splenic artery embolization before laparoscopic splenectomy. An update. Surg Endosc 12:6 (1998), 870–875.
41. Rudowski, W.J., Accessory spleens: clinical significance with particular reference to the recurrence of idiopathic thrombocytopenic purpura. World J Surg 9:3 (1985), 422–430.
42. Swanson, T.W., Meneghetti, A.T., Sampath, S., et al. Hand-assisted laparoscopic splenectomy versus open splenectomy for massive splenomegaly: 20-year experience at a Canadian centre. Can J Surg J Can Chir 54:3 (2011), 189–193.
43. Winslow, E.R., Brunt, L.M., Perioperative outcomes of laparoscopic versus open splenectomy: a meta-analysis with an emphasis on complications. Surgery 134:4 (2003), 647–653 [Discussion 654–5].
44. Targarona, E.M., Balague, C., Cerdán, G., et al. Hand-Assisted Laparoscopic Splenectomy (HALS) in cases of splenomegaly: a comparison analysis with conventional laparoscopic splenectomy. Surg Endosc 16:3 (2002), 426–430.
45. Barbaros, U., Dinççağ A., Sümer, A., et al. Prospective randomized comparison of clinical results between hand-assisted laparoscopic and open splenectomies. Surg Endosc 24:1 (2010), 25–32.
46. Targarona, E.M., Lima, M.B., Balague, C., et al. Single-port splenectomy: current update and controversies. J Minimal Access Surg 7:1 (2011), 61–64.
47. Gelmini, R., Franzoni, C., Spaziani, A., et al. Laparoscopic splenectomy: conventional versus robotic approach– a comparative study. J Laparoendosc Adv Surg Tech A 21:5 (2011), 393–398.
48. Giulianotti, P.C., Buchs, N.C., Addeo, P., et al. Robot-assisted partial and total splenectomy. Int J Med Robot 7:4 (2011), 482–488.
49. Espert, J.J., Targarona, E.M., Bombuy, E., et al. Evaluation of risk of splenosis during laparoscopic splenectomy in rat model. World J Surg 25:7 (2001), 882–885.
50. Tchernia, G., Gauthier, F., Mielot, F., et al. Initial assessment of the beneficial effect of partial splenectomy in hereditary spherocytosis. Blood 81:8 (1993), 2014–2020.
51. Slater, B.J., Chan, F.P., Davis, K., et al. Institutional experience with laparoscopic partial splenectomy for hereditary spherocytosis. J Pediatr Surg 45:8 (2010), 1682–1686.
52. Davies, J.M., Lewis, M.P.N., Wimperis, J., et al. Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. Br J Haematol 155:3 (2011), 308–317.
53. Romano, F., Caprotti, R., Conti, M., et al. Thrombosis of the splenoportal axis after splenectomy. Langenbecks Arch Surg 391:5 (2006), 483–488.
54. Ha, L.P., Arrendondo, M., Fatal venous thromboembolism after splenectomy: pathogenesis and management. J Am Osteopath Assoc 112:5 (2012), 291–300.
55. Ikeda, M., Sekimoto, M., Takiguchi, S., et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 241:2 (2005), 208–216.
56. Kristinsson, S.Y., Gridley, G., Hoover, R.N., et al. Long-term risks after splenectomy among 8149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica 99:2 (2014), 392–398.